Drug Database
Back to search

Poland· PL-100203906

Cazaprol

A cilazapril product containing cilazaprilum, registered in Poland by Krka, d.d., Novo mesto. The same ATC class is registered in 10 of our 19 countries.

ATC C09AA08

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCazaprolATCC09AA08REGISTER NO.PL-100203906PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cilazaprilumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cilazapril is registered in 10 of 19 countries.

Countries holding a registration under ATC C09AA08 (cilazapril), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search cilazapril products by name

Cilazapril · ATC C09AA08

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Germany
  • Italyprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cilazapril costs, country by country.

Normalised to the WHO defined daily dose (2.5 mg), the median price runs from $0.22 in Spain to $0.53 in Switzerland — a ×2.4 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Cilazapril · price per daily dose (2.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.53
  • IT Italy$0.45
  • ES Spain$0.22
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Cilazaprilum
Manufacturer
Krka, d.d., Novo mesto
Country
Poland (PL)
ATC code
C09AA08
ATC class
Cilazapril
Defined daily dose
2.5 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990678655
  • gtin
    05909990678662

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

69 interactions on record for cilazapril.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cilazapril against other medicinesHow interaction checks work

Cilazapril · interactions on record

69 records

69 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Cilazapril in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cilazapril products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Austria · Inhibace
  • Belgium · Inhibace
  • Czechia · Cazaprol, Inhibace
  • Germany · Dynorm
  • United Kingdom (Northern Ireland) · Cilazapril Activase Pharmaceuticals
  • Greece · Vascace
  • Hungary · Inhibace
  • Italy · Inibace, Initiss
  • Portugal · Cilazapril Generis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0ca05888-4b0a-433c-93a1-b9fdd35f04e3
GET /v1/drugs/0ca05888-4b0a-433c-93a1-b9fdd35f04e3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "2,5 mg",
  "packaging": "05909990678655 ¦ Rp ¦ 48049\n28 tabl.\n05909990678662 ¦ Rp ¦ 48050\n30 tabl.",
  "substance": "Cilazaprilum 2.5 mg",
  "common_name": "Cilazaprilum",
  "pl_product_id": "100203906",
  "pozwolenie_nr": "15106",
  "auth_procedure": "MRP",
  "authorisation_validity": "2026-01-14"
}
API referenceMCP serverPlans

See everything about cilazapril.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console